LabPad INR got CE marked this month for patient self-testing following a conformity assessment conducted by BSI Healthcare, a UK based notified body. While LabPad INR was made available since December 2017 for healthcare professional only, this is a key milestone that will pave our way towards full commercial launch at the beginning of 2018, with an initial focus on the European market. Further tests are under development, with a focus on cardiovascular diseases application.
top of page
bottom of page